| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/18/1997 | CA2250319A1 Polyvalent polymers for the treatment of rotavirus infection |
| 09/18/1997 | CA2248978A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | CA2248707A1 Clostridium perfringens vaccines |
| 09/18/1997 | CA2248657A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | CA2248192A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | CA2247888A1 Human bikunin |
| 09/18/1997 | CA2225913A1 Persephin and related growth factors |
| 09/17/1997 | EP0795549A1 Bis-aryloxy(amino)-triazinyl-oxy(amino)aryl derivatives, their preparation and their use as antiviral agents |
| 09/17/1997 | EP0794955A1 Hindered n-oxide esters of rapamycin and their use as medicaments |
| 09/17/1997 | EP0794954A1 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 09/17/1997 | EP0794794A1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 09/17/1997 | EP0794793A1 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 09/17/1997 | EP0794787A1 Compositions for the treatment of parasitic and fungal infections |
| 09/17/1997 | EP0794781A1 Drugs to prevent recurrent herpes virus infections |
| 09/17/1997 | EP0794776A2 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections |
| 09/17/1997 | EP0755675B1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 09/17/1997 | EP0537280B1 Preparation and use of transfer factor |
| 09/17/1997 | CN1159830A Immunomodulators |
| 09/17/1997 | CN1159809A Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 09/17/1997 | CN1159803A Substituted Arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
| 09/17/1997 | CN1159761A Vaccine compositions |
| 09/17/1997 | CN1159760A Enteral vaccine for vaginal infections |
| 09/16/1997 | US5668291 Thiosubstituted pyridines, treatment of aids and hiv |
| 09/16/1997 | US5668284 Cephalosporin derivatives |
| 09/16/1997 | US5668168 1,2-dithiin antiinfective agents |
| 09/16/1997 | US5668167 Treatment of pneumocystis pneumonia with carbazole derivatives |
| 09/16/1997 | US5668166 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor |
| 09/16/1997 | US5668165 Small molecule inhibition of RNA/ligand binding |
| 09/16/1997 | US5668162 Isothiazolones lower plasma levels of lipoprotein(a) |
| 09/16/1997 | US5668143 Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action |
| 09/16/1997 | US5668134 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications |
| 09/16/1997 | US5668132 HIV Protease inhibitors useful for the treatment of AIDS |
| 09/16/1997 | US5668131 Controlling helicobacter bacteria |
| 09/16/1997 | US5668130 Medicament for treating gastrointestinal disorders |
| 09/16/1997 | US5668127 Nitroimidazole antibacterial compounds and methods of use thereof |
| 09/16/1997 | US5668113 Method of using 1,5-anhydrohexitol nucleoside analogues to treat viral infections |
| 09/16/1997 | US5668105 Aza cyclohexapeptide compounds |
| 09/16/1997 | US5667991 Recombinant mersacidin and a method for production |
| 09/16/1997 | US5667965 Papillomavirus E2 trans-activation repressors |
| 09/16/1997 | US5667800 Lotions with lipids and emulsifiers |
| 09/16/1997 | US5667787 Purification of a pertussis outer membrane protein |
| 09/16/1997 | US5667764 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 09/16/1997 | US5667492 Use and composition of an anti-sexually transmitted diseases formulation |
| 09/16/1997 | CA2171887A1 An anti-viral and anti-cancer agent |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032983A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | WO1997032973A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound |
| 09/12/1997 | WO1997032887A1 Oligonucleotide analogues |
| 09/12/1997 | WO1997032607A2 Activated linkers and methods for making and purifying the same |
| 09/12/1997 | WO1997032596A1 Intercellular adhesion molecule powder formulation |
| 09/12/1997 | WO1997032586A1 Caffeine and clemastine for treating respiratory disorders |
| 09/12/1997 | WO1997032480A1 A method of killing or inhibiting microbial cells |
| 09/12/1997 | WO1997026880A3 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
| 09/12/1997 | WO1997026320A3 Product for inhibition of attachment of h. influenzae to human cells |
| 09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/12/1997 | WO1997008199A3 Antimicrobial cationic peptides and methods of screening for the same |
| 09/12/1997 | CA2248065A1 A method of killing or inhibiting microbial cells |
| 09/12/1997 | CA2247500A1 Caffeine and clemastine for treating respiratory disorders |
| 09/12/1997 | CA2247480A1 Oligonucleotide analogues |
| 09/12/1997 | CA2247091A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | CA2244894A1 Intercellular adhesion molecule powder formulation |
| 09/10/1997 | EP0793728A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
| 09/10/1997 | EP0793722A2 Modified proteinase inhibitors |
| 09/10/1997 | EP0793719A2 Rna component of telomerase |
| 09/10/1997 | EP0793676A1 Novel membrane proteins of helicobacter pylori |
| 09/10/1997 | EP0793675A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 09/10/1997 | EP0793669A1 L-nucleoside dimer compounds and therapeutic uses |
| 09/10/1997 | EP0793656A1 Novel benzyl pyrimidines |
| 09/10/1997 | EP0793654A1 Antibacterial dibenzimidazole derivatives |
| 09/10/1997 | EP0793484A1 Adjuvant for a vaccine composition |
| 09/10/1997 | EP0793472A1 Method of using lectins for agglutination and collection of menstrual flow |
| 09/10/1997 | EP0734249A4 Novel and improved aminoglycoside formulation for aerosolization |
| 09/10/1997 | EP0689454B1 Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/10/1997 | EP0675724B1 Use of dideoxy nucleoside analogues in the treatment of viral infections |
| 09/10/1997 | EP0566644B1 Method of removing endotoxins |
| 09/10/1997 | EP0466833B1 Protease inhibitor |
| 09/10/1997 | CN1159209A Recombinant herpesvirus with the use of gB Gene promoter |
| 09/10/1997 | CN1159197A Purified form of streptogramines, preparation thereof and pharmacueitcal compositions containing it |
| 09/10/1997 | CN1159194A Therapeutic compounds |
| 09/10/1997 | CN1159183A BIS-(2-haloethyl) aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 09/10/1997 | CN1159158A Antibacterial oil-in-water emulsions |
| 09/10/1997 | CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals |
| 09/10/1997 | CN1158844A Tertiary amines |
| 09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
| 09/09/1997 | US5665873 Inhibits reactivation of herpes virus |
| 09/09/1997 | US5665779 Pharmaceutical composition for inhibiting the infection with AIDS virus |
| 09/09/1997 | US5665772 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 09/09/1997 | US5665751 Pharmaceutical composition for inhibiting the growth of cancers |
| 09/09/1997 | US5665746 Bactericide |
| 09/09/1997 | US5665737 Phosphodiesterase inhibitors |
| 09/09/1997 | US5665717 Antibacterial antibiotics |
| 09/09/1997 | US5665703 GE3 compound |
| 09/09/1997 | US5665580 Antisense oligonucleotide inhibition of papillomavirus transformed cells |
| 09/09/1997 | US5665561 Administering one or more carbohydrate entities, such as a disaccharide with an n-acetyl-d-glucosamine motif |
| 09/09/1997 | US5665552 Antibodies to plasmodium falciparum |
| 09/09/1997 | US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell |
| 09/09/1997 | US5665355 Diagnosis and treatment of AIDS onset |
| 09/09/1997 | US5665353 Composition containing an analog of haemophilus Hin47 with reduced protease activity |
| 09/09/1997 | US5665328 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 09/09/1997 | CA1339450C Stable oxapenem-3-carboxylic acids |